TMF inhibits extracellular matrix degradation by regulating the C/EBPβ/ADAMTS5 signaling pathway in osteoarthritis
Zeyu Wang(Anhui University), Jianguo Zhou(Ganzhou People's Hospital), Yaosheng Xiao(Soochow University), Zhixi Chen(Tongji University), Longhuo Wu(Gannan Medical University), Sainan Zhang(Wenzhou Medical University), Guoqiang Yin(Ganzhou People's Hospital), Weihao Kong(Ganzhou People's Hospital), Xunlu Xie(Ganzhou People's Hospital), Shengrong Bi(Ganzhou People's Hospital), Miaofei Wang(Gannan Medical University), Shiwei Liu(University of Illinois Urbana-Champaign), Weimei Shi(Gannan Medical University)
Cited by 11
Related Papers
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273